How Long Ipamorelin Stays in Your System: Half-Life

The short version

How long does ipamorelin stay in your system? In humans, the terminal half-life — the time for blood levels to drop by half during the clearance phase — is about 2 hours ^[2]. Pharmacology uses a rule of thumb: after roughly four to five half-lives, a compound is mostly gone. That puts near-complete clearance of the parent peptide at about 8 to 10 hours.

The growth-hormone response is even quicker and shorter: a single burst that peaks near 40 minutes after dosing ^[2]. So the felt 'pulse' is over fast, and the peptide itself clears within hours, not days. One important caveat: how long it stays detectable in an anti-doping test is a separate question from how long it stays active, and the detection window can outlast clearance. Those two clocks are not the same, and the sections below keep them apart.

The human half-life number

The 1999 population PK/PD study is the source. In healthy male volunteers (n=8 per dose level), across five 15-minute IV infusions from 4.21 to 140.45 nmol/kg, the kinetics were dose-proportional ^[2]. The headline figures: terminal half-life about 2 hours, clearance 0.078 L/h/kg, steady-state volume of distribution 0.22 L/kg ^[2].

Dose-proportional means doubling the dose roughly doubled exposure — a clean, linear profile. This is the only human pharmacokinetic dataset of its kind for ipamorelin, which is why every credible half-life figure traces back to it.

The GH pulse versus the peptide

Two timelines run here, and they differ. The peptide's own clearance follows the ~2-hour half-life ^[2]. The growth-hormone response it triggers is a single discrete pulse that peaks near 0.67 h — about 40 minutes — after dosing ^[2].

So the GH signal rises and falls quickly on its own schedule, while the peptide concentration decays separately. Neither persists for days. The GH pulse is the measured pharmacodynamic event; community claims of multi-day 'GH elevation' from a single ipamorelin dose are not supported by this kinetic profile.

Clearance in animals

Animal data is consistent with rapid clearance. In rats, ipamorelin's plasma clearance is roughly 5-fold lower than GHRP-6 — meaning it lingers somewhat longer than that older peptide, but still clears on a short timescale rather than accumulating. The ipamorelin-derived oral analog NN703 showed a longer 4.1-hour half-life in dogs ^[7], but that is an engineered, structurally modified molecule built specifically for oral durability — not ipamorelin itself. The parent peptide's profile is the short one.

Detection is a different clock

Clearance and detectability are not the same. Ipamorelin is prohibited in sport at all times under the WADA Prohibited List, category S2, as a growth hormone secretagogue, and accredited anti-doping laboratories detect it in urine. A 2026 critical review specifically notes that ipamorelin's short half-life creates analytical challenges for detection, even as the testing framework expands ^[13].

The practical point: a roughly 2-hour active half-life ^[2] does not mean a 2-hour detection window. Detection methods target the parent compound or its signature in urine and can register it outside the active window. This site does not provide detection-window estimates — it notes only that the two clocks differ and that detection is established.